Hikal Ltd (HIKA)

NSE
Currency in INR
405.05
+5.25(+1.31%)
Closed
HIKA Scorecard
Full Analysis
Trading at a high earnings multiple
Fair Value
Day's Range
395.15407.40
52 wk Range
262.40464.75
Key Statistics
Edit
Bid/Ask
404.10 / 405.05
Prev. Close
399.8
Open
397
Day's Range
395.15-407.4
52 wk Range
262.4-464.75
Volume
191.11K
Average Vol. (3m)
244.04K
1-Year Change
48.35%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HIKA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth
Show more

Hikal Ltd Company Profile

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Employees
2061
Market
India

Compare HIKA to Peers and Sector

Metrics to compare
HIKA
Peers
Sector
Relationship
P/E Ratio
66.0x21.4x−0.5x
PEG Ratio
16.480.210.00
Price / Book
4.1x4.4x2.6x
Price / LTM Sales
2.7x3.0x3.0x
Upside (Analyst Target)
7.4%13.3%57.1%
Fair Value Upside
Unlock12.2%10.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.04%
Dividend Yield
0.30%
Industry Median 0.71%
Annualized Payout
1.20
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 04, 2025
EPS / Forecast
4.10 / --
Revenue / Forecast
4.00B / 4.39B
EPS Revisions
Last 90 days

People Also Watch

1,688.25
DATP
-0.26%
509.85
ANRA
+2.33%
1,041.10
KFIN
-0.24%
1,377.20
PROO
+1.57%

FAQ

What Is the Hikal Ltd (HIKA) Stock Price Today?

The Hikal Ltd stock price today is 405.05

What Stock Exchange Does Hikal Ltd Trade On?

Hikal Ltd is listed and trades on the NSE stock exchange.

What Is the Stock Symbol for Hikal Ltd?

The stock symbol for Hikal Ltd is "HIKA."

Does Hikal Ltd Pay Dividends? What’s The Current Dividend Yield?

The Hikal Ltd dividend yield is 0.30%.

What Is the Hikal Ltd Market Cap?

As of today, Hikal Ltd market cap is 49.91B.

What is Hikal Ltd Earnings Per Share?

The Hikal Ltd EPS is 6.04.

What Is the Next Hikal Ltd Earnings Date?

Hikal Ltd will release its next earnings report on May 08, 2025.

From a Technical Analysis Perspective, Is HIKA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.